A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

BACKGROUND: Guillain-Barré syndrome (GBS) is an immune-mediated neuropathy that causes acute flaccid paralysis. Immunoglobulin and plasma exchange are established treatments for GBS; however, a substantial number of patients, particularly those with severe disease, have poor recovery and residual de...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Nobuko, Misawa, Sonoko, Sato, Yasunori, Nagashima, Kengo, Katayama, Kanako, Sekiguchi, Yukari, Iwai, Yuta, Amino, Hiroshi, Suichi, Tomoki, Yokota, Takanori, Nishida, Yoichiro, Kohara, Nobuo, Hirata, Koichi, Nishiyama, Kazutoshi, Yabe, Ichiro, Kaida, Ken-Ichi, Suzuki, Norihiro, Nodera, Hiroyuki, Tsuji, Shoji, Koike, Haruki, Kira, Jun-Ichi, Hanaoka, Hideki, Kusunoki, Susumu, Kuwabara, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2016
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118582/
https://www.ncbi.nlm.nih.gov/pubmed/27821382
http://dx.doi.org/10.2196/resprot.6610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118582/
https://www.ncbi.nlm.nih.gov/pubmed/27821382
http://dx.doi.org/10.2196/resprot.6610

Ejemplares similares